CYCN - Cyclerion Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
10.76
+0.98 (+10.02%)
At close: 4:00PM EDT

10.76 0.00 (0.00%)
After hours: 4:48PM EDT

Stock chart is not supported by your current browser
Previous Close9.78
Open9.67
Bid10.67 x 800
Ask10.71 x 900
Day's Range9.56 - 10.79
52 Week Range9.10 - 22.85
Volume144,854
Avg. Volume171,077
Market Cap294.842M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Ironwood Initiates Dosing in Mid-Stage Study for MD-7246
    Zacks12 days ago

    Ironwood Initiates Dosing in Mid-Stage Study for MD-7246

    Ironwood (IRWD)and its partner initiate dosing in a phase II study evaluating delayed-release version of Linzess, MD-7246, in patients with IBS-D.

  • GuruFocus.com13 days ago

    3 Spinoff Stocks Worth Your Attention

    Joel Greenblatt (Trades, Portfolio)'s "You Can Be a Stock Market Genius" prompted many investors to follow spinoff stocks with close attention. Gurus like Peter Lynch, Charlie Munger (Trades, Portfolio) and Seth Klarman (Trades, Portfolio) do as well. Warning! GuruFocus has detected 1 Warning Sign with BCS.

  • Cyclerion taps ex-Shire exec as chief innovation officer
    American City Business Journals2 months ago

    Cyclerion taps ex-Shire exec as chief innovation officer

    Cyclerion has hired the former chief medical officer at Shire plc for a new, overarching role focused on bridging R&D;, external partnerships and other business facets.